Human clinical trials have not established GLP-1 receptor agonists as treatments for anemia
The disadvantage is that one-size-fits-all formulations cannot account for individual deficiency patterns, which vary significantly based on baseline nutritional status, specific medication, dose, and diet quality
Try to create a diet of primarily healthy proteins and fats while avoiding processed foods and refined sugars
NNMT is an enzyme involved in nicotinamide metabolism and energy-related pathways
For Sjgrens syndrome and ankylosing spondylitis, we dont yet have specific large trials but the same underlying biology applies: calm the metabolic inflammation, and the autoimmune attack often calms with it
Tara *Based on internal survey 416 GLP-1 users in 2025 **Based on survey responses of 166 participants in a 6-month clinical trial who had overweight or obesity, and were taking semaglutide/tirzepatide for weight loss within the WW Clinic Program and participating in the GLP-1 companion nutrition program